173 related articles for article (PubMed ID: 21157405)
1. Clinical significance of regulatory T-cell-related gene expression in peripheral blood after renal transplantation.
Iwase H; Kobayashi T; Kodera Y; Miwa Y; Kuzuya T; Iwasaki K; Haneda M; Katayama A; Takeda A; Morozumi K; Watarai Y; Uchida K; Nakao A
Transplantation; 2011 Jan; 91(2):191-8. PubMed ID: 21157405
[TBL] [Abstract][Full Text] [Related]
2. Forkhead box P3 (FOXP3) mRNA expression immediately after living-donor liver transplant.
Sakamoto R; Asonuma K; Zeledon Ramirez ME; Yoshimoto K; Nishimori A; Inomata Y
Exp Clin Transplant; 2009 Mar; 7(1):8-12. PubMed ID: 19364305
[TBL] [Abstract][Full Text] [Related]
3. Absolute of CD4(+)CD25(+)FOXP3(+) regulatory T-cell count rather than its ratio in peripheral blood is related to long-term survival of renal allografts.
Liu L; Deng S; Teng L; Fu Q; Wang C; He X
Transplant Proc; 2012 Jan; 44(1):284-6. PubMed ID: 22310634
[TBL] [Abstract][Full Text] [Related]
4. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
5. Discontinuation of calcineurin inhibitors treatment allows the development of FOXP3+ regulatory T-cells in patients after kidney transplantation.
van de Wetering J; Koumoutsakos P; Peeters A; van der Mast BJ; de Kuiper P; IJzermans JN; Weimar W; Baan CC
Clin Transplant; 2011; 25(1):40-6. PubMed ID: 20636406
[TBL] [Abstract][Full Text] [Related]
6. FoxP3 in peripheral blood is associated with operational tolerance in liver transplant patients during immunosuppression withdrawal.
Pons JA; Revilla-Nuin B; Baroja-Mazo A; Ramírez P; Martínez-Alarcón L; Sánchez-Bueno F; Robles R; Rios A; Aparicio P; Parrilla P
Transplantation; 2008 Nov; 86(10):1370-8. PubMed ID: 19034005
[TBL] [Abstract][Full Text] [Related]
7. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome.
Braudeau C; Racape M; Giral M; Louis S; Moreau A; Berthelot L; Heslan M; Ashton-Chess J; Soulillou JP; Brouard S
Transpl Int; 2007 Oct; 20(10):845-55. PubMed ID: 17854443
[TBL] [Abstract][Full Text] [Related]
8. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?
Batsford S; Dickenmann M; Dürmüller U; Hopfer H; Gudat F; Mihatsch M
Clin Nephrol; 2011 Feb; 75(2):101-6. PubMed ID: 21255538
[TBL] [Abstract][Full Text] [Related]
9. T-cell phenotype in protocol renal biopsy from transplant recipients treated with belatacept-mediated co-stimulatory blockade.
Grimbert P; Audard V; Diet C; Matignon M; Plonquet A; Mansour H; Desvaux D; Durrbach A; Cohen JL; Lang P
Nephrol Dial Transplant; 2011 Mar; 26(3):1087-93. PubMed ID: 20667993
[TBL] [Abstract][Full Text] [Related]
10. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection.
Kollins D; Stoelcker B; Hoffmann U; Bergler T; Reinhold S; Banas MC; Rümmele P; Farkas S; Krämer BK; Banas B
Clin Nephrol; 2011 Feb; 75(2):91-100. PubMed ID: 21255537
[TBL] [Abstract][Full Text] [Related]
11. The role of Foxp3+ regulatory T cells in kidney transplantation.
Karczewski M; Karczewski J; Kostrzewa A; Wiktorowicz K; Glyda M
Transplant Proc; 2009 Jun; 41(5):1527-9. PubMed ID: 19545671
[TBL] [Abstract][Full Text] [Related]
12. Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients.
Segundo DS; Ruiz JC; Izquierdo M; Fernández-Fresnedo G; Gómez-Alamillo C; Merino R; Benito MJ; Cacho E; Rodrigo E; Palomar R; López-Hoyos M; Arias M
Transplantation; 2006 Aug; 82(4):550-7. PubMed ID: 16926600
[TBL] [Abstract][Full Text] [Related]
13. Forkhead box protein 3 mRNA expression in the peripheral blood of kidney-transplant recipients with acute rejection.
Wang W; Li XB; Yang XY; Zhang XD
Chin Med J (Engl); 2011 Jun; 124(12):1775-8. PubMed ID: 21740831
[TBL] [Abstract][Full Text] [Related]
14. Differential monocyte STAT6 activation and CD4(+)CD25(+)Foxp3(+) T cells in kidney operational tolerance transplanted individuals.
Moraes-Vieira PM; Silva HM; Takenaka MC; Monteiro SM; Lemos F; Saitovitch D; Kalil J; Coelho V
Hum Immunol; 2010 May; 71(5):442-50. PubMed ID: 20122976
[TBL] [Abstract][Full Text] [Related]
15. WOFIE stimulates regulatory T cells: a 2-year follow-up of renal transplant recipients.
Dresske B; Haendschke F; Lenz P; Ungefroren H; Jenisch S; Exner B; El Mokhtari NE; Lu T; Zavazava N; Faendrich F
Transplantation; 2006 Jun; 81(11):1549-57. PubMed ID: 16770244
[TBL] [Abstract][Full Text] [Related]
16. The regulatory/cytotoxic graft-infiltrating T cells differentiate renal allograft borderline change from acute rejection.
Grimbert P; Mansour H; Desvaux D; Roudot-Thoraval F; Audard V; Dahan K; Berrehar F; Dehoulle-Poillet C; Farcet JP; Lang P; Le Gouvello S
Transplantation; 2007 Feb; 83(3):341-6. PubMed ID: 17297410
[TBL] [Abstract][Full Text] [Related]
17. Short-term anti-CD25 monoclonal antibody treatment and neogenetic CD4(+)CD25(high) regulatory T cells in kidney transplantation.
Wang Z; Xiao L; Shi BY; Qian YY; Bai HW; Chang JY; Cai M
Transpl Immunol; 2008 Apr; 19(1):69-73. PubMed ID: 18346640
[TBL] [Abstract][Full Text] [Related]
18. Low circulating regulatory T-cell levels after acute rejection in liver transplantation.
Demirkiran A; Kok A; Kwekkeboom J; Kusters JG; Metselaar HJ; Tilanus HW; van der Laan LJ
Liver Transpl; 2006 Feb; 12(2):277-84. PubMed ID: 16447185
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of regulatory T cells in kidney graft recipients: a relationship with calcineurin inhibitor level.
Calvo-Turrubiartes M; Romano-Moreno S; García-Hernández M; Chevaile-Ramos JA; Layseca-Espinosa E; González-Amaro R; Portales-Pérez D
Transpl Immunol; 2009 May; 21(1):43-9. PubMed ID: 19233271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
